Stockscreener 앱 받기
26.94
0.19%
-0.05
시간 외 거래:
26.91
-0.03
-0.11%
Anaptysbio Inc 주식(ANAB)의 최신 뉴스
AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Victory Capital Management Inc. Acquires 71,980 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for AnaptysBio (NASDAQ:ANAB) Stock - Defense World
AnaptysBio (NASDAQ:ANAB) Price Target Raised to $80.00 at JPMorgan Chase & Co. - MarketBeat
Is AnaptysBio Inc. a good long term investmentConsistently high yield - PrintWeekIndia
Does AnaptysBio Inc. stock pay reliable dividendsOutstanding trading profits - jammulinksnews.com
Trading (ANAB) With Integrated Risk Controls - news.stocktradersdaily.com
What drives AnaptysBio Inc. stock priceOutstanding trading profits - jammulinksnews.com
AnaptysBio Inc. Stock Analysis and ForecastConsistent triple-digit returns - jammulinksnews.com
What analysts say about AnaptysBio Inc. stockHigh-yield portfolio picks - jammulinksnews.com
How AnaptysBio Inc. stock performs during market volatilityFree Access to Community with 300% Return - Newser
AnaptysBio, Inc.'s (NASDAQ:ANAB) Share Price Not Quite Adding Up - simplywall.st
What makes AnaptysBio Inc. stock price move sharplyShort Squeeze Radar - Newser
Why AnaptysBio Inc. stock attracts strong analyst attentionLow Volatility High Yield Stocks - Newser
AnaptysBio (ANAB) Soars 2.86% on Two Sigma Stake Increase - AInvest
AnaptysBio: Potential Promise, But Some Cause For Skepticism (NASDAQ:ANAB) - Seeking Alpha
(ANAB) Trading Report - news.stocktradersdaily.com
AnaptysBio (NASDAQ:ANAB) Stock Price Up 7.6%What's Next? - MarketBeat
Moody Aldrich Partners LLC Acquires New Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
AnaptysBio, Inc. (NASDAQ:ANAB) Director Sells $493,202.25 in Stock - MarketBeat
AnaptysBio, Inc. (ANAB) Stock Analysis: A High-Risk, High-Reward Bet with a 79% Potential Upside - DirectorsTalk Interviews
(ANAB) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
AnaptysBio, Inc. (NASDAQ:ANAB) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Farther Finance Advisors LLC Increases Position in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
GAMMA Investing LLC Acquires New Stake in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
When the Price of (ANAB) Talks, People Listen - news.stocktradersdaily.com
Rhumbline Advisers Grows Position in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
Assenagon Asset Management S.A. Has $4.51 Million Stock Position in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
AnaptysBio, Inc. (NASDAQ:ANAB) Holdings Trimmed by Bank of America Corp DE - MarketBeat
AnaptysBio Holds 2025 Annual Stockholders Meeting - TipRanks
Bank of America Corp DE Lowers Stock Position in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Purchased by California State Teachers Retirement System - Defense World
FMR LLC Significantly Reduces Stake in AnaptysBio Inc - GuruFocus
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $390,000 Position in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
JPMorgan Sees AnaptysBio (ANAB) as Undervalued Due to Rosnilimab - GuruFocus
Shareholders May Be More Conservative With AnaptysBio, Inc.'s (NASDAQ:ANAB) CEO Compensation For Now - simplywall.st
0.97%
0.22%
자본화:
|
볼륨(24시간):